Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Bernardi

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell TransplantationMatteo G Della Porta, Anna Gallì, Andrea Bacigalupo, et al.
Hematological Oncology|August 7, 2019
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapyMonica Bocchia, Anna Candoni, Erika Borlenghi, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Cancer|January 24, 2023
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemiaElisabetta Todisco, Cristina Papayannidis, Nicola Fracchiolla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO TrialUwe Platzbecker, Lionel Adès, Pau Montesinos, et al.
American Journal of Hematology|September 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell TransplantationFabio Guolo, Luana Fianchi, Maria Paola Martelli, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell TransplantationMatteo G Della Porta, Anna Gallì, Andrea Bacigalupo, et al.
Hematological Oncology|August 7, 2019
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapyMonica Bocchia, Anna Candoni, Erika Borlenghi, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Cancer|January 24, 2023
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemiaElisabetta Todisco, Cristina Papayannidis, Nicola Fracchiolla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO TrialUwe Platzbecker, Lionel Adès, Pau Montesinos, et al.
American Journal of Hematology|September 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell TransplantationFabio Guolo, Luana Fianchi, Maria Paola Martelli, et al.
Pageof 10